British Columbia Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,142
Closed -$1.28M 738
2024
Q2
$1.28M Sell
10,142
-41,271
-80% -$6.47M 0.01% 681
2024
Q1
$9.46M Buy
51,413
+3,233
+7% +$616K 0.07% 200
2023
Q4
$8.66M Buy
48,180
+1,319
+3% +$205K 0.07% 202
2023
Q3
$7.45M Buy
46,861
+4,087
+10% +$668K 0.07% 199
2023
Q2
$6.05M Buy
42,774
+2,585
+6% +$414K 0.06% 240
2023
Q1
$6.77M Buy
40,189
+14,500
+56% +$2.59M 0.07% 224
2022
Q4
$4.35M Buy
+25,689
New +$4.66M 0.05% 279

Other funds holding RGEN

British Columbia Investment Management's RGEN Position: Q3 2024 in Review

British Columbia Investment Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 10,142 shares — an estimated $1.28M sold.

British Columbia Investment Management first reported a position in RGEN in Q4 2022 and held it in 7 quarters. The position peaked at $9.46M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • British Columbia Investment Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • British Columbia Investment Management sold 10,142 Repligen shares in Q3 2024, an estimated $1.28M.
  • British Columbia Investment Management first reported a position in Repligen in Q4 2022 and held it in 7 quarters.
  • British Columbia Investment Management's Repligen position peaked at $9.46M in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on British Columbia Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.